HOME - Clinical cases - Periodontology
 
 
28 April 2025

Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology


Issues related to peri-implant disease were discussed. It was observed that the most common lesions that occur, i.e. peri-implant mucositis and peri-implantitis are caused by bacteria. While the lesion of peri-implant mucositis resides in the soft tissues, peri-implantitis also affects the supporting bone.

Peri-implant mucositis occurs in about 80% of subjects (50% of sites) restored with implants, and peri-implantitis in between 28% and 56% of subjects (12–40% of sites). A number of risk indicators were identified including (i) poor oral hygiene, (ii) a history of periodontitis, (iii) diabetes and (iv) smoking. It was concluded that the treatment of peri-implant disease must include anti-infective measures. With respect to peri-implant mucositis, it appeared that non-surgical mechanical therapy caused the reduction in inflammation (bleeding on probing) but also that the adjunctive use of antimicrobial mouthrinses had a positive effect. It was agreed that the outcome of non-surgical treatment of peri-implantitis was unpredictable.

The primary objective of surgical treatment in peri-implantitis is to get access to the implant surface for debridement and decontamination in order to achieve resolution of the inflammatory lesion. There was limited evidence that such treatment with the adjunctive use of systemic antibiotics could resolve a number of peri-implantitis lesions. There was no evidence that so-called regenerative procedures had additional beneficial effects on treatment outcome.


Authors: Jan Lindhe, Joerg Meyle

Source: https://onlinelibrary.wiley.com/

Related articles

The diagnosis of peri-implantar and periodontal relies mainly on a set of clinical measures and the evaluation of radiographic images. However, these clinical settings alone are not sufficient to...


Over six years, Align has contributed more than $2M to Operation Smile’s student programs to send the next generation of global health advocates to the world stage.


In a testament to ongoing innovation and industry-leading technology, Carestream Dental’s CS 9600 CBCT system has earned its sixth consecutive Cellerant Best of Class Technology Award, having won...


Read more

George Freedman gives readers a brief summary of products that have re­cent­ly been in­troduced to den­tistry, based on his clinical experience.


Partnership leverages BioHorizons’ commercial network to broaden availability of Xtant’s allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand


(“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, recently announced several key initiatives to support the drive toward ca


The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas


This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


 
 
 
 

 
 
 
 

Most popular

 
 

Events